Endovascular Aneurysm Repair Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028

 

Endovascular Aneurysm Repair 

Due to its benefits over open surgery, Endovascular Aneurysm Repair (EVAR) is a favoured method of treating aortic aneurysm. These benefits include absence of abdominal surgery, quicker recovery times, and better patient outcomes. The EVAR operation is hence known as the "standard intervention" for abdominal aortic aneurysm (AAA). In this operation, a stent is inserted into the aorta's aneurysmal area to create a permanent alternate blood flow pathway within the patient's vasculature and stop the aneurysmal sac from being under blood flow pressure and rupturing.

Even though EVAR considerably reduces operating room dangers and recovery time when compared to open surgery, Endovascular Aneurysm Repair Market still has room for development. This is explained by the endoleak incidents that have occurred after EVAR procedures. However, market participants have created cutting-edge technologies of the next generation in order to overcome such difficulties. For instance, Endologix Inc., the first and only endovascular sealing solution helpful in preventing all forms of endoleaks, has game-changing new generation Nellix technology and got FDA approval for its percutaneous endograft delivery system.

In 2021, the Endovascular Aneurysm Repair Market in North America still held a decisive 33% of the global market. It is brought on by the high prevalence of aneurysms and the conditions that encourage their development. Additionally, the area focuses on developing and innovating dependable medical infrastructure products, which further helps the market's growth. About 116 million adults in the USA, or about half of all adults, have hypertension, which is a primary contributor of aneurysms. The Centers for Disease Control and Prevention estimate that there are 17,220 aneurysms recorded per year in North America.

A 2016 study in the New England Journal of Medicine found a significant rise in patients choosing endovascular aneurysm repair between 2005 and 2012. For instance, in 2005, almost 50% of aneurysm patients in the U.S. chose EVAR; by 2012, that number had climbed to 75.4%. In England, a similar pattern was seen. Customers' growing interest in this ground-breaking surgery is attributable to the fact that it uses a minimally invasive treatment approach that promotes quick healing, requires little hospital time, and leaves fewer scars. This is anticipated to support market expansion.

Product Type

·       Fenestrated Stent Graft

·       Adjunctive Stent Graft

·       Branched Stent Graft

·       Others

By Indication

·       Abdominal Aortic Aneurysm (AAA)

·       Thoracic Aortic aneurysm (TAA)

·       Descending Aortic Aneurysm

·       Ascending Aortic Aneurysm

By End Users

·       Hospitals

·       Ambulatory care services

·       Specialty clinics

Major Companies are Medtronic plc. Cook Medical, Gore Medical, B. Braun Melsungen AG, Terumo Corporation, Boston Scientific Corporation, Abbott Laboratories, Volcano Corporation, C.R. Bard, Spectranetics International BV, Cordis Corporation (Johnson and Johnson Co.), and St. Jude Medical Inc.